Proteomic-guided targeted treatment of leukoencephalopathy with calcification and cysts.
Detailed protein analysis of brain tissue guided precision treatment of an extremely rare neurological disease, demonstrating personalized medicine for untreatable conditions.
This study presents the first application of spatially-resolved proteomics to a patient with leukoencephalopathy with calcification and cysts, uncovering a novel disease mechanism and guiding successful precision pharmacotherapy. For an extremely rare condition with no established treatment, this case represents a proof-of-concept for proteomics-guided precision medicine in rare neurological diseases.
What the study was
- Study design
- Proof-of-concept translational study (spatially-resolved proteomics)
- Population
- Leukoencephalopathy with calcification and cysts (LCC) patients (ultra-rare)
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Brain : a journal of neurology
Why it surfaced
First proteomics-guided precision treatment for an ultra-rare neurological disease with no prior therapeutic options; exemplifies scalable precision medicine approach for rare diseases.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.